Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting

(2013) Tiewei Cheng et al.   PLoS One

The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II

(2012) Brian B. Hasinoff et al.   BIOCHEMICAL PHARMACOLOGY

Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation

(2011) D. Yao et al.   MOLECULAR CANCER RESEARCH

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo

(2010) F R Lamont et al.   BRITISH JOURNAL OF CANCER

Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes

(2010) Jonas Fuxe et al.   CELL CYCLE

Cadherin Switching and Bladder Cancer

(2010) Richard T. Bryan et al.   JOURNAL OF UROLOGY

Roles for Growth Factors in Cancer Progression

(2010) Esther Witsch et al.   PHYSIOLOGY

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

(2009) David J. McConkey et al.   CANCER AND METASTASIS REVIEWS

Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer

(2009) D. C. Tomlinson et al.   CANCER RESEARCH

Molecular Pathogenesis and Diagnostics of Bladder Cancer

(2008) Anirban P. Mitra et al.   Annual Review of Pathology-Mechanisms of Disease

P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells

(2008) Jessica A. Mandeville et al.   BJU INTERNATIONAL

Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells

(2008) P. C. Black et al.   CLINICAL CANCER RESEARCH

Cadherin switching dictates the biology of transitional cell carcinoma of the bladder:ex vivo andin vitro studies

(2008) RT Bryan et al.   JOURNAL OF PATHOLOGY

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

(2008) A Jeanes et al.   ONCOGENE